Money present
Biotech

A new benchmark for biotech IPOs? Kailera raises $625M

Kailera appears to have set a new benchmark for biotech IPOs with an upsized $625 million offering to fund its pipeline of obesity therapies.
James Waldron Apr 17, 2026 4:42am
light bulb think theory idea bright dull lights out

Small pools, big ideas: Rare disease community reimagines trials

Apr 17, 2026 3:00am
Biotech Giants and Investors Gather to Solve the Commercialisation Puzzle This May in Hong Kong

ASGH 2026: Solving the Biotech Commercialisation Puzzle

merck

Merck unveils PD-1xVEGF bispecific data in NSCLC

Apr 17, 2026 3:00pm
Beyond the Hype Turning NAMs into Actionable Evidence

Beyond the Hype: Turning NAMs into Actionable Evidence

Brought to you by Battelle
UCB sign

UCB strikes $1.15B deal for cell therapy biotech Neurona

Apr 17, 2026 1:55pm
More News

Metsera sale architect swings to Structure—Chutes & Ladders

Apr 17, 2026 10:10am

OpenAI launches biotech-specific AI model dubbed GPT-Rosalind

Apr 17, 2026 10:00am

Roivant’s CEO thinks China is a ‘red herring’

Apr 17, 2026 8:35am

RyghtAI launches clinical trial site search engine

Apr 16, 2026 2:35pm